Skip to main content
Clinical Trials/NCT02729584
NCT02729584
Completed
Not Applicable

Gene Polymorphism of Taste Receptors and Circulating Endocannabinoids in Normal Weight and Obese Subjects

University of Cagliari0 sites110 target enrollmentApril 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nutritional Physiological Phenomena
Sponsor
University of Cagliari
Enrollment
110
Primary Endpoint
Endocannabinoid plasma levels
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The study aims at evaluating in normal weight and obese subjects those factors such as taste sensitivity and circulating endocannabinoids in influencing dietary choice and thereby lipid and energy metabolism in order to design personalized nutritional strategies.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
September 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sebastiano Banni

Professor

University of Cagliari

Eligibility Criteria

Inclusion Criteria

  • Body Mass Index (BMI), range for normal weight subjects 17.5-24.95, for obese subjects 29.6-52.20
  • No intake of nutritional supplements for at least six months before the trial

Exclusion Criteria

  • major diseases (diabetes, kidney disease, etc.),
  • pregnancy or lactation;
  • food allergies;
  • the use of medications that interfere with taste or smell (e.g., steroids, antihistamines, certain antidepressants).

Outcomes

Primary Outcomes

Endocannabinoid plasma levels

Time Frame: 1 year

Similar Trials